Dr. Velagapudi's PRP therapy claims need more evidence

What did @aara_gynecare actually say?

Honestly, this is a difficult fact-check to write, because the transcript is largely unintelligible. The video is captioned as a patient testimonial about PRP therapy for lichen sclerosus and urinary incontinence, with the caption claiming "cosmetic gynecology isn't just about appearance; it's about function, comfort, and care." But the actual spoken transcript, attributed to Dr. Rukmini Samya, is a fragmented, incoherent series of phrases that don't constitute a medical claim in any coherent sense. Phrases like "the image is very different" and "you will feel very very perfect" are repeated without clinical context. We can only fact-check the framing claims in the caption, not the spoken content, because there is no coherent spoken content to evaluate.

What the caption does assert is meaningful enough to scrutinize: that PRP therapy addresses lichen sclerosus and urinary incontinence as a functional, not merely cosmetic, intervention. That claim is worth examining on its own.

Does the science back this up?

The short answer is: partially, and with significant caveats. PRP for vulvar lichen sclerosus has a small but growing evidence base, and it is not junk science, but calling it established treatment is a stretch. A 2020 randomized controlled trial by Behnia-Willison et al. published in the Journal of Lower Genital Tract Disease found that platelet-rich plasma injections reduced symptoms and improved histological findings in patients with vulvar lichen sclerosus compared to controls. That is a real finding. But the sample sizes in these studies are consistently small, follow-up periods are short, and standardization of PRP preparation varies widely between clinics, which makes results hard to compare.

For urinary stress incontinence, the evidence is similarly preliminary. A 2019 pilot study by Mourkus et al. found modest improvement in stress urinary incontinence symptoms following periurethral PRP injection, but pilot studies are hypothesis-generating, not practice-defining. The American Urogynecologic Society does not currently list PRP as a standard-of-care treatment for incontinence. Patients deserve to know that distinction.

What did they get wrong (or right)?

The caption framing is defensible. Lichen sclerosus is genuinely a condition affecting function and quality of life, not just appearance, and framing its treatment as functional healthcare rather than vanity medicine is accurate and arguably overdue. Credit where it's due: the stigma around vulvar conditions leads to undertreatment, and reducing that stigma has real clinical value.

What is problematic is the implicit promise structure of the video. Patient testimonials paired with "real healing" language create the impression of reliable, repeatable outcomes. A single patient's positive experience, presented without any discussion of response rates, side effects, or the fact that PRP is not FDA-cleared for these specific indications, is marketing dressed as education. The phrase "you will feel very very perfect" in the transcript, however garbled, reflects the tone of the content: outcome promises that the clinical literature does not support at the population level. PRP does not work for everyone, and no credible provider should imply otherwise.

What should you actually know?

If you have lichen sclerosus, first-line treatment remains high-potency topical corticosteroids like clobetasol, which have decades of evidence behind them. PRP is an adjunct or alternative being explored in cases where standard treatments fail or cause side effects, not a replacement backed by Level 1 evidence. A 2022 systematic review by Casabona et al. in the Journal of the European Academy of Dermatology and Venereology concluded that PRP shows promise but that evidence quality remains low and larger controlled trials are needed.

For urinary incontinence, pelvic floor physical therapy remains the most evidence-supported non-surgical intervention. PRP is experimental in this context. That does not mean it is wrong to try, but patients should enter any PRP protocol with clear expectations: this is an emerging intervention, results vary, and the absence of FDA clearance for these indications means the regulatory bar for proving it works has not yet been met. Ask your provider what their clinic's response rate looks like, and be cautious of anyone who cannot answer that question.